Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2012
10/18/2012US20120263809 Nutritional Supplement Comprising Nut and Seed Oil Composition
10/18/2012US20120263808 Bioavailability enhancing compound
10/18/2012US20120263804 Essential element extractor
10/18/2012US20120263802 Use of Quinazoline Derivative ZD6474 Combined With Platinum Compounds and Optionally Ionising Radiation in the Treatment of Diseases Associated With Angiogenesis and/or Increased Vascular Permeability
10/18/2012US20120263795 Aqueous suspensions of submicron 9-hydroxyrisperidone fatty acid esters
10/18/2012US20120263793 Bio-nano-plasmonic elements and platforms
10/18/2012US20120263792 Dual drug dosage forms with improved separation of drugs
10/18/2012US20120263791 Fomulation comprising 1 h-quinazoline-2, 4-dione ampa receptor antagonists, in the form of immediate release tablets and preparation thereof
10/18/2012US20120263790 Methods of diagnosing and treating small intestinal bacterial overgrowth (sibo) and sibo-related conditions
10/18/2012US20120263789 Delayed release rasagiline formulation
10/18/2012US20120263788 Controlled release hydrocodone formulations
10/18/2012US20120263786 Pharmaceutical Formulations Containing an SGLT2 Inhibitor
10/18/2012US20120263785 Stable cannabinoid compositions and methods for making and storing them
10/18/2012US20120263784 Emergency contraceptive
10/18/2012US20120263783 Single molecule nucleic acid nanoparticles
10/18/2012US20120263782 Methods and compositions for treating hiv infection
10/18/2012US20120263780 Carbohydrate Entrapped Active Agent Delivery Composition and Articles Using the Same
10/18/2012US20120263779 Biodegradable drug delivery system
10/18/2012US20120263766 Formulations
10/18/2012US20120263762 Stabilised particles comprising 5-methyl-(6s)-tetrahydrofolate
10/18/2012US20120263761 Shelf stable pharmaceutical depot
10/18/2012US20120263760 Novel formulation of metaxalone
10/18/2012US20120263759 Coating Comprising An Elastin-Based Copolymer
10/18/2012US20120263754 Methods for Enhancing Immunogen Specific Immune Responses by Vectored Vaccines
10/18/2012US20120263738 Multiplex dicer substrate rna interference molecules having joining sequences
10/18/2012US20120263737 Methods for inhibiting allograft rejection
10/18/2012US20120263736 Method for predicting and treating a sterile inflammation and discriminating between sterile and infective inflammation
10/18/2012US20120263730 Receptors of rspo2 and rspo3
10/18/2012US20120263729 Compositions and methods for treating cardiovascular disease
10/18/2012US20120263721 Therapeutic Combination and Methods of Treatment With a DLL4 Antagonist and an Anti-Hypertensive Agent
10/18/2012US20120263716 Method of treating cancers and a pharmaceutical composition that may be used in practicing said method
10/18/2012US20120263714 Substituted halophenoxybenzamide derivatives
10/18/2012US20120263712 Pyrrolidine-1,2-dicarboxamide derivatives
10/18/2012US20120263709 Use of il-33 antagonists to treat fibrotic diseases
10/18/2012US20120263708 Substituted aminoquinoxalines as tyrosine threonine kinase inhibitors
10/18/2012US20120263706 Enantiomerically pure aminoheteroaryl compounds as protein kinase inhibitors
10/18/2012US20120263702 Human Aminoacyl-tRNA Synthetase Polypeptides Useful For The Regulation of Angiogenesis
10/18/2012US20120263698 Treatment of Neurodegenerative Disease
10/18/2012US20120263696 Indirect Substrates for Microorganisms Metabolizing 1,2-Propanediol
10/18/2012US20120263691 Modular aptamer-regulated ribozymes
10/18/2012US20120263679 Combinations Comprising Heterocyclic Inhibitors of MEK and Methods of Use Thereof
10/18/2012US20120263678 1'-substituted pyrimidine n-nucleoside analogs for antiviral treatment
10/18/2012US20120263677 Combination of Local and Systemic Immunomodulative Therapies for Enhanced Treatment of Cancer
10/18/2012US20120263676 Compositions, methods and kits relating to her-2 cleavage
10/18/2012US20120263675 Bivalent diazo bicyclic smac
10/18/2012US20120263672 Biocompatible Adhesive Materials and Methods
10/18/2012US20120263670 Compounds and methods for inhibiting nhe-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders
10/18/2012US20120263667 Composition and method for modulating and maintaining vaginal bacterial flora and vaginal acidity
10/18/2012US20120263666 Topical skin care composition
10/18/2012US20120263660 Hair Loss Treatment
10/18/2012US20120263659 Use of physiological cooling active ingredients, and agents containing such active ingredients
10/18/2012US20120263657 Promoting Whole Body Health
10/18/2012US20120263655 Combination of medicaments for the treatment of respiratory diseases
10/18/2012US20120263654 Melanoma specific biomarker
10/18/2012US20120263653 Methods and systems for generating nanoparticles
10/18/2012US20120263651 Single Stranded DNA Aptamers Binding NF-kB/RelA
10/18/2012US20120263650 Nitroxide modified non-steroidal anti-inflammatory compounds and uses thereof in the treatment and prevention of diseases or disorders
10/18/2012US20120260922 Topical use of hydroxytyrosol and derivatives for the prevention of hiv infection
10/18/2012DE102011007310A1 Verfahren zur Bestimmung der metabolischen Leistung mindestens eines Enzyms A method of determining the metabolic performance of at least one enzyme
10/18/2012DE102011007272A1 Verzweigte 3-Phenylpropionsäure-Derivate und ihre Verwendung Branched 3-phenylpropionic acid derivatives and their use
10/18/2012CA2833313A1 Phenyl bicyclic methyl amine derivatives as sphingosine-1 phosphate receptors modulators
10/18/2012CA2833305A1 Phenyl bicyclic methyl azetidine derivatives as sphingosine-1 phosphate receptors modulators
10/18/2012CA2833301A1 Substituted bicyclic methyl azetidines as sphingosine-1 phosphate receptors modulators
10/18/2012CA2833296A1 Fused imidazole derivatives useful as ido inhibitors
10/18/2012CA2833269A1 Agents for improved delivery of nucleic acids to eukaryotic cells
10/18/2012CA2833255A1 Bicyclic methyl amine derivatives as sphingosine-1 phosphate receptors modulators
10/18/2012CA2833180A1 Novel piperidinyl monocarboxylic acids as s1p1 receptor agonists
10/18/2012CA2833159A1 N-acetyl beta alanine methods of use
10/18/2012CA2833101A1 Febuxostat solid dispersion
10/18/2012CA2833078A1 Treatment of microbial infections
10/18/2012CA2833043A1 Use of s-adenosylmethionine, vitamin e, and vitamin c for the prevention and treatment of cardiovascular dysfunction
10/18/2012CA2832972A1 Antisense modulation of ptp1b expression
10/18/2012CA2832970A1 Branched 3-phenylpropionic acid derivatives and the use thereof
10/18/2012CA2832958A1 Glycoside derivatives and their use for the treatment of diabetes
10/18/2012CA2832953A1 Compositions and methods for the treatment of nasal conditions
10/18/2012CA2832951A1 Glycoside derivatives and uses thereof
10/18/2012CA2832933A1 Methods for treating bacterial infection
10/18/2012CA2832899A1 Micro-rna inhibitors and their uses in disease
10/18/2012CA2832886A1 Polymer conjugated prostaglandin analogues
10/18/2012CA2832859A1 Treatment of disease with poly-n-acetylglucosamine nanofibers
10/18/2012CA2832858A1 Solid pharmaceutical composition
10/18/2012CA2832846A1 Substituted benzene compounds
10/18/2012CA2832843A1 Aryl-or heteroaryl-substituted benzene compounds
10/18/2012CA2832822A1 Heterocyclic compounds and uses thereof in the treatment of sexual disorders
10/18/2012CA2832817A1 Parp inhibitors for the treatment of cipn
10/18/2012CA2832787A1 Chromenone compounds as pi 3 - kinase inhibitors for the treatment of cancer
10/18/2012CA2832758A1 Antihypertensive pharmaceutical composition
10/18/2012CA2832704A1 Tri- and tetracyclic pyrazolo[3,4-b]pyridine compounds as antineoplastic agent
10/18/2012CA2832686A1 Peptidyl arginine deiminase 1 and/or 3 activator compounds in the epidermis and uses thereof
10/18/2012CA2832680A1 Screening methods and pharmaceutical compositions for the treatment of inflammatory bowel diseases
10/18/2012CA2832650A1 Novel pyrazole derivative
10/18/2012CA2832611A1 Methods for inhibiting allograft rejection
10/18/2012CA2832505A1 Inhibitors of viral replication, their process of preparation and their therapeutical uses
10/18/2012CA2832473A1 5-substituted iminothiazines and their mono-and dioxides as bace inhibitors, compositions, and their use
10/18/2012CA2832467A1 1,3 oxazines as bace1 and/or bace2 inhibitors
10/18/2012CA2832459A1 2'-substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases
10/18/2012CA2832449A1 2'-cyano substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases
10/18/2012CA2832203A1 Unit dose form for oral administration
10/18/2012CA2831933A1 Substituted catechols as inhibitors of il-4 and il-5 for the treatment bronchial asthma
10/18/2012CA2831679A1 Nutritional compositions including branched chain fatty acids for improving gut barrier function
1 ... 995 996 997 998 999 1000 1001 1002 1003 1004 1005 1006 1007 1008 1009 1010 1011 1012 1013 1014 1015 ... 7860